The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity - Concepedia

Concepedia

Publication | Open Access

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

DOI Full Paper Access

28

Citations

54

References

2011

Year

Wieslawa H. Dragowska, Sherry A. Weppler, Mohammed A. Qadir, Ling Yan Wong, Yannick Franssen, Jennifer HE Baker, Anita I. Kapanen, Guido J. J. Kierkels, Dana Masin, Andrew I. Minchinton,

References

	Year	Citations

Page 1